Leia a Última Edição!

II Serie Volume 34 Number 9
September 2021


menu esquerda

  1- Factors of recurrence of intraepithelial lesions of the uterine cervix.

2- Duodenoscopy and endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis of biliary and pancreatic pathology.

3- Mephedrone (?Meow Meow?), The New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynimics and Clinical and Forensic Issues

4- Natural history of fetal pyelocaliectasia.

5- Antidepressant drugs.

6- Erysipelas.

7- Pressure ulcer management--Evidence-based interventions.

8- Traumatic Brain Injury: Integrated Approach

9- Genital ulcers caused by sexually transmitted diseases: current therapies, diagnosis and their relevance in HIV pandemy.

10- Current management of gout.

11- Livedo vasculitis.

12- Tarlov's cyst: definition, etiopathogenesis, propaedeutic and treatment.

13- Antibiotic treatment of uncomplicated cystitis in non-pregnant women up to menopause.

14- Urolithiasis and renal colic. Therapeutic approach in urology.

15- Uterine inversion.

16- Autoimmune lymphoproliferative syndrome.

17- Autoimmune lymphoproliferative syndrome.

18- Sarcoidosis in an adolescent.

19- Sarcoidosis in an adolescent.

20- Frontotemporal dementia.


The Stool Color Card as a Screening Tool for Biliary Atresia in the Digital Version of the Portuguese Child and Youth Health Booklet

Biliary atresia (BA) is a rare entity (incidence in Europe of 1/18 000 live births) leading to great morbidity and mortality and represents the first indication for pediatric liver transplantation. The long-term prognosis depends on the timing of bile flow restoration (Kasai portoenterostomy). One of the major determining factors of prognosis and survival of the native liver is surgical intervention before 45 days of life. 
Taiwan has one of the highest incidence rates of BA in the world. Therefore, a universal screening program was started there in 2002, using a validated stool color card (SCC). Subsequently, in 2011, it was observed that the median age of patients undergoing Kasai portoenterostomy decreased substantially, thus improving prognosis. Meanwhile, other countries have demonstrated the cost-effectiveness of this tool, and some have already started using it as a teaching and surveillance tool, by enrolling parents and caregivers. In Portugal, and as far as we know, there have been no initiatives at the level of the central healthcare system on this matter.is surgical intervention before 45 days of life.


Click here for the full text of the Letter to the Editor.